Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".

Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo

Potestio, Luca; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo.

Potestio L; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Camela E; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Megna M; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

J Cosmet Dermatol ; 20(12): 4073-4075, 2021 12.

Article in English | MEDLINE | ID: covidwho-1488221

Subject(s)

Biological Products; COVID-19; Psoriasis; Attitude; Humans; Pandemics; Psoriasis/drug therapy; SARS-CoV-2

Keywords

COVID-19; biologic treatment; psoriasis; psoriasis management

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Cosmet Dermatol Journal subject: Dermatology Year: 2021 Document Type: Article Affiliation country: Jocd.14550

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google